The aim of this study was to assess the clinical efficacy of gamma knife surgery (GKS) in the treatment of dural arteriovenous shunts (DAVSs).
From a database of more than 1600 patients with intracranial arteriovenous shunts that had been treated with GKS, the authors retrospectively and prospectively identified 53 patients with 58 DAVSs from the period between 1978 and 2003. Four patients were lost to follow-up evaluation and were excluded from the series. Thus, this study is based on the remaining 49 patients with 52 DAVSs. Thirty-six of the shunts drained into the cortical venous system, either directly or indirectly, and 22 of these were associated with intracranial hemorrhage on patient presentation. The mean prescription radiation dose was 22 Gy (range 10–28 Gy).
All patients underwent a clinical follow-up examination. In 41 cases of DAVS a follow-up angiography study was performed. At the 2-year follow-up visit, 28 cases (68%) had angiographically proven obliteration of the shunt and in another 10 cases (24%) there was significant flow regression. Three shunts remained unchanged.
There was one immediate minor complication related to the administration of radiation. Furthermore, one patient had a radiation-induced complication 10 years after treatment, although she recovered completely. There was one posterior fossa bleed 2 months after radiosurgery; a hematoma, as well as a lesion, was evacuated, and the patient recovered uneventfully. A second patient had an asymptomatic occipital hemorrhage approximately 6 months postradiosurgery.
The clinical outcome after GKS was significantly better than that in patients with naturally progressing shunts (p < 0.01, chi-square test); figures on the latter have been reported previously.
Gamma knife surgery is an effective treatment for DAVSs, with a low risk of complications. Major disadvantages of this therapy include the time elapsed before obliteration and the possibility that not all shunts will be obliterated. Cortical venous drainage from a DAVS, a risk factor for intracranial hemorrhage, is therefore a relative contraindication. Consequently, GKS can be used in the treatment of both benign DAVSs with subjectively intolerable bruit and aggressive DAVSs not responsive to endovascular treatment or surgery.
Barcia-SalorioJL, , SolerF, , BarciaJA, & HernandezG: Stereotactic radiosurgery for the treatment of low-flow carotid-cavernous fistulae: results in a series of 25 cases. Stereotact Funct Neurosurg63:266–270, 1994
Barcia-SalorioJL, SolerF, BarciaJA, HernandezG: Stereotactic radiosurgery for the treatment of low-flow carotid-cavernous fistulae: results in a series of 25 cases. Stereotact Funct Neurosurg63:266–270, 199410.1159/000100330)| false
BordenJA, WuJK, ShucartWA: A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg82:166–179, 199510.3171/jns.1995.82.2.0166)| false
CastaigneP, , BoriesJ, , BrunetP, , CassanJL, , MeiningerV, & MerlandJJ: Fistules arterio-veineuses de la dure-mere, Etude clinique et radiologique de 13 observations. Ann Med Interne (Paris)126:813–817, 1975
CastaigneP, BoriesJ, BrunetP, CassanJL, MeiningerV, MerlandJJ: Fistules arterio-veineuses de la dure-mere, Etude clinique et radiologique de 13 observations. Ann Med Interne (Paris)126:813–817, 1975)| false
DaviesMA, TerBruggeK, WillinskyR, CoyneT, SalehJ, WallaceMC: The validity of classification for the clinical presentation of intracranial dural arteriovenous fistulas. J Neurosurg85:830–837, 199610.3171/jns.1996.85.5.0830)| false
DaviesMA, TerBruggeK, WillinskyR, WallaceC: The natural history and management of intracranial dural arteriovenous fistulae. Part 2: aggressive lesions. Intervent Neuroradiol3:303–311, 199710.1177/159101999700300405)| false
DuffauH, , LopesM, , JanosevicV, , SichezJP, , FaillotT, & CapelleL, et al.: Early rebleeding from intracranial dural arteriovenous fistulas: report of 20 cases and review of the literature. J Neurosurg90:78–84, 1999
DuffauH, LopesM, JanosevicV, SichezJP, FaillotT, CapelleL, : Early rebleeding from intracranial dural arteriovenous fistulas: report of 20 cases and review of the literature. J Neurosurg90:78–84, 199910.3171/jns.1999.90.1.0078)| false
FriedmanJA, PollockBE, NicholsDA, GormanDA, FooteRL, StaffordSL: Results of combined stereotactic radiosurgery and transarterial embolization for dural arteriovenous fistulas of the transverse and sigmoid sinuses. J Neurosurg94:886–891, 200110.3171/jns.2001.94.6.0886)| false
KarlssonB, LaxI, SödermanM: Can the probability for obliteration after radiosurgery of arteriovenous malformations be accurately predicted?. Int J Radiat Onc Biol Phys43:313–319, 199910.1016/S0360-3016(98)00396-4)| false
KihlstromL, GuoWY, KarlssonB, LindquistC, LindqvistM: Magnetic resonance imaging of obliterated arteriovenous malformations up to 23 years after radiosurgery. J Neurosurg86:589–593, 199710.3171/jns.1997.86.4.0589)| false
LasjauniasP, , HalimiP, , Lopez-IborL, , SichezJP, , HurthM, & De TriboletN: Traitement endovasculaire des malformations vasculaires durales (MVD) pures “spontanees”. Revue de 23 cas explores et traites entre mai 1980 et octobre 1983. Neurochirurgie30:207–223, 1984
LasjauniasP, HalimiP, Lopez-IborL, SichezJP, HurthM, De TriboletN: Traitement endovasculaire des malformations vasculaires durales (MVD) pures “spontanees”. Revue de 23 cas explores et traites entre mai 1980 et octobre 1983. Neurochirurgie30:207–223, 1984)| false
LinkMJ, CoffeyRJ, NicholsDA, GormanDA: The role of radio-surgery and particulate embolization in the treatment of dural arteriovenous fistulas. J Neurosurg84:804–809, 199610.3171/jns.1996.84.5.0804)| false
MederJF, , OppenheimC, , BlustajnJ, , NatafF, , MerienneL, & LefkoupolosD, et al.: Cerebral arteriovenous malformations: the value of radiologic parameters in predicting response to radiosurgery. AJNR Am J Neuroradiol18:1473–1483, 1997
MederJF, OppenheimC, BlustajnJ, NatafF, MerienneL, LefkoupolosD, : Cerebral arteriovenous malformations: the value of radiologic parameters in predicting response to radiosurgery. AJNR Am J Neuroradiol18:1473–1483, 1997)| false
OnizukaM, MoriK, TakahashiN, KawaharaI, HiuT, TodaK, : Gamma knife surgery for the treatment of spontaneous dural carotid-cavernous fistulas. Neurol Med Chir (Tokyo)43:477–483, 200310.2176/nmc.43.477)| false
RothbartD, AwadIA, LeeJ, KimJ, HarbaughR, CriscuoloGR: Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery38:915–925, 199610.1097/00006123-199605000-00011)| false
ShinM, KuritaH, TagoM, KirinoT: Stereotactic radiosurgery for tentorial dural arteriovenous fistulae draining into the vein of Galen: report of two cases. Neurosurgery46:730–734, 200010.1097/00006123-200003000-00039)| false
TeradaT, HigashidaRT, HalbachVV, DowdCF, TsuuraM, KomaiN, : Development of acquired arteriovenous fistulas in rats due to venous hypertension. J Neurosurg80:884–889, 199410.3171/jns.1994.80.5.0884)| false
TirakotaiW, , BianLG, , BertalanffyH, , SiegfriedB, & SureU: Immunohistochemical study in dural arteriovenous fistula and possible role of ephrin-B2 for development of dural arteriovenous fistula. Chin Med J (Engl)117:1815–1820, 2004
TirakotaiW, BianLG, BertalanffyH, SiegfriedB, SureU: Immunohistochemical study in dural arteriovenous fistula and possible role of ephrin-B2 for development of dural arteriovenous fistula. Chin Med J (Engl)117:1815–1820, 2004)| false